中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
36期
223-225
,共3页
陈念东%杜娟%杨永%立伟%徐连宝%张雪玲
陳唸東%杜娟%楊永%立偉%徐連寶%張雪玲
진념동%두연%양영%립위%서련보%장설령
轻度帕金森病样体征%轻度认知功能损害%社区老年人
輕度帕金森病樣體徵%輕度認知功能損害%社區老年人
경도파금삼병양체정%경도인지공능손해%사구노년인
Mild parkinsonian signs%Mild cognitive impairment%Community elderly people
目的:调查社区老年人轻度帕金森病样体征的患病率,研究伴有轻度帕金森病样体征(MPS)与轻度认知功能损害(MCI)之间的关系。方法以492例≥60岁老年人为研究对象,使用帕金森病统一评分量表(the unified Parkinson’s disease rating scale, UPDRS)第3部分缩写版本评定MPS。将研究对象分为MPS组和无MPS组,比较MCI患病情况,分析MPS与MCI之间联系。结果 MPS组较无MPS组的年龄大,糖尿病比例、遗忘型MCI (MCI-amnestic, A-MCI)发病率高,差异有统计学意义(P<0.05)。结论 MPS与MCI的发生关系密切,不同类型MPS对MCI影响不同。
目的:調查社區老年人輕度帕金森病樣體徵的患病率,研究伴有輕度帕金森病樣體徵(MPS)與輕度認知功能損害(MCI)之間的關繫。方法以492例≥60歲老年人為研究對象,使用帕金森病統一評分量錶(the unified Parkinson’s disease rating scale, UPDRS)第3部分縮寫版本評定MPS。將研究對象分為MPS組和無MPS組,比較MCI患病情況,分析MPS與MCI之間聯繫。結果 MPS組較無MPS組的年齡大,糖尿病比例、遺忘型MCI (MCI-amnestic, A-MCI)髮病率高,差異有統計學意義(P<0.05)。結論 MPS與MCI的髮生關繫密切,不同類型MPS對MCI影響不同。
목적:조사사구노년인경도파금삼병양체정적환병솔,연구반유경도파금삼병양체정(MPS)여경도인지공능손해(MCI)지간적관계。방법이492례≥60세노년인위연구대상,사용파금삼병통일평분량표(the unified Parkinson’s disease rating scale, UPDRS)제3부분축사판본평정MPS。장연구대상분위MPS조화무MPS조,비교MCI환병정황,분석MPS여MCI지간련계。결과 MPS조교무MPS조적년령대,당뇨병비례、유망형MCI (MCI-amnestic, A-MCI)발병솔고,차이유통계학의의(P<0.05)。결론 MPS여MCI적발생관계밀절,불동류형MPS대MCI영향불동。
Objective To research the morbidity of mild parkinsonian signs (MPS) in community elderly people, and the relation between mild cognitive impairment (MCI) and mild cognitive impairment (MCI). Methods A total of 492 elderly people, who≥60 years old, were selected as the study subjects. The unified Parkinson’s disease rating scale (UPDRS) part 3 abbreviated version was applied to assess MPS. The study subjects were divided into MPS group and non-MPS group. Their MCI condition was compared, and the relation between MPS and MCI was analyzed. Results MPS group had older age than the non-MPS group, and it had higher morbidity of diabetes mellitus and MCI-amnestic (A-MCI). The difference had statistical significance. Conclusion There is a close relation between MPS and MCI, and different type of MPS has various influence on MCI.